BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 30945756)

  • 1. The D-dimer assay.
    Johnson ED; Schell JC; Rodgers GM
    Am J Hematol; 2019 Jul; 94(7):833-839. PubMed ID: 30945756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Test in Context: D-Dimer.
    Weitz JI; Fredenburgh JC; Eikelboom JW
    J Am Coll Cardiol; 2017 Nov; 70(19):2411-2420. PubMed ID: 29096812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. D-dimer assays in diagnosis and management of thrombotic and bleeding disorders.
    Bates SM
    Semin Thromb Hemost; 2012 Oct; 38(7):673-82. PubMed ID: 23041982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. D-dimer: An Overview of Hemostasis and Fibrinolysis, Assays, and Clinical Applications.
    Olson JD
    Adv Clin Chem; 2015; 69():1-46. PubMed ID: 25934358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated fibrin-related markers in patients with malignant diseases frequently associated with disseminated intravascular coagulation and venous thromboembolism.
    Yamashita Y; Wada H; Nomura H; Mizuno T; Saito K; Yamada N; Asanuma K; Usui M; Kamimoto Y; Matsumoto T; Ohishi K; Katayama N
    Intern Med; 2014; 53(5):413-9. PubMed ID: 24583428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D-dimer testing: A narrative review.
    Wauthier L; Favresse J; Hardy M; Douxfils J; Le Gal G; Roy PM; van Es N; Ay C; Ten Cate H; Lecompte T; Lippi G; Mullier F
    Adv Clin Chem; 2023; 114():151-223. PubMed ID: 37268332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How we manage a high D-dimer.
    Franchini M; Focosi D; Pezzo MP; Mannucci PM
    Haematologica; 2024 Apr; 109(4):1035-1045. PubMed ID: 37881856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Appropriate use of D-dimer in hospital patients.
    Thachil J; Fitzmaurice DA; Toh CH
    Am J Med; 2010 Jan; 123(1):17-9. PubMed ID: 20102984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. D-dimer and its relationship to fibrinogen/fibrin degradation products (FDPs) in disorders associated with activation of coagulation or fibrinolytic systems.
    Moresco RN; Vargas LC; Voegeli CF; Santos RC
    J Clin Lab Anal; 2003; 17(3):77-9. PubMed ID: 12696076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D-dimer: Preanalytical, analytical, postanalytical variables, and clinical applications.
    Favresse J; Lippi G; Roy PM; Chatelain B; Jacqmin H; Ten Cate H; Mullier F
    Crit Rev Clin Lab Sci; 2018 Dec; 55(8):548-577. PubMed ID: 30694079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. D-dimer testing in pregnancy.
    Eichinger S
    Pathophysiol Haemost Thromb; 2003 Sep-2004 Dec; 33(5-6):327-9. PubMed ID: 15692237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D-dimer testing in laboratory practice.
    Tripodi A
    Clin Chem; 2011 Sep; 57(9):1256-62. PubMed ID: 21719689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct reactivity of the commercially available monoclonal antibodies of D-dimer and plasma FDP testing to the molecular variants of fibrin degradation products.
    Madoiwa S; Kitajima I; Ohmori T; Sakata Y; Mimuro J
    Thromb Res; 2013 Oct; 132(4):457-64. PubMed ID: 24011388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative evaluation of assays for markers of activated coagulation and/or fibrinolysis: thrombin-antithrombin complex, D-dimer and fibrinogen/fibrin fragment E antigen.
    Boisclair MD; Lane DA; Wilde JT; Ireland H; Preston FE; Ofosu FA
    Br J Haematol; 1990 Apr; 74(4):471-9. PubMed ID: 2189490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased activation of blood coagulation in pregnant women with the Factor V Leiden mutation.
    Kjellberg U; van Rooijen M; Bremme K; Hellgren M
    Thromb Res; 2014 Oct; 134(4):837-45. PubMed ID: 25135795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D-Dimer Testing: Laboratory Aspects and Current Issues.
    Thachil J; Lippi G; Favaloro EJ
    Methods Mol Biol; 2017; 1646():91-104. PubMed ID: 28804821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reference intervals of D-dimer during the pregnancy and puerperium period on the STA-R evolution coagulation analyzer.
    Wang M; Lu S; Li S; Shen F
    Clin Chim Acta; 2013 Oct; 425():176-80. PubMed ID: 23954836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A test for the detection of fibrin in the plasma].
    Franke M; Hafter R; von Hugo R; Röbl M; Graeff H
    Geburtshilfe Frauenheilkd; 1986 Feb; 46(2):105-9. PubMed ID: 3956964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Evaluation of Fibrin-Related Markers for Diagnosing or Predicting Acute or Subclinical Venous Thromboembolism in Patients Undergoing Major Orthopedic Surgery.
    Hasegawa M; Wada H; Miyazaki S; Yamaguchi T; Wakabayashi H; Fujimoto N; Matsumoto T; Ohishi K; Sakaguchi A; Yamada N; Ito M; Yamashita Y; Katayama N; Nakatani K; Sudo A
    Clin Appl Thromb Hemost; 2018 Jan; 24(1):107-114. PubMed ID: 28301902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations between venous thromboembolism onset, D-dimer, and soluble fibrin monomer complex after total knee arthroplasty.
    Mitani G; Takagaki T; Hamahashi K; Serigano K; Nakamura Y; Sato M; Mochida J
    J Orthop Surg Res; 2015 Nov; 10():172. PubMed ID: 26555394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.